CRDF
#4031
Cardiff Oncology, Inc. - Common Stock
1.3 1 USD
-0.03%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.96%
Variación mensual
-9.66%
Variación en los últimos 6 meses
-53.21%
Cambio anual
-68.28%
Cierres anteriores
1.3 5
Open
1.3 1
Mínimo
1.3 1
High
1.3 1
Volumen
94
Financials
- Market Capitalization 89.56 M
- Employee 31
- Founded 1999
- CEO Mark Erlander
- Website www.cardiffoncology.com
- Headquarter Delaware, United States
- FIGI BBG000PXLKM7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.07
Relación precio/flujo de caja
316.73
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4019 |  ACRV Acrivon Therapeutics, Inc. - Common Stock | 2.13 USD | +7.58% | +14.52% | +40.13% | +65.12% | 91.17 M USD | ||
| 4023 |  CGTX Cognition Therapeutics, Inc. - Common Stock | 1.01 USD | -0.98% | -6.48% | -17.21% | +57.81% | 90.39 M USD | ||
| 4033 |  LONA LeonaBio, Inc. - Common Stock | 9.52 USD | -2.46% | +12.13% | +12.40% | +41.25% | 89.43 M USD | ||
| 4040 |  MAIA MAIA Biotechnology, Inc. Common Stock | 1.45 USD | +2.11% | -3.97% | +7.41% | -30.29% | 88.16 M USD |